Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NexStent® Carotid Stent System: A Post Market Approval Evaluation Study In Conjunction With the FilterWire EZ™ Embolic Protection System

NCT00478673 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00478673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00478673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NexStent® Carotid Stent System: A Post Market Approval Evaluation Study In Conjunction With the FilterWire EZ™ Embolic Protection System
Lead sponsor
Boston Scientific Corporation
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2007
Completion date
July 31, 2009
Enrollment
298 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

carotid stenosis